UK & International Distribution
In the UK and across Europe, Aegerion Pharmaceuticals UK manages the distribution of its lead products — Juxtapid® and Myalept® — through established partners and specialty pharmacies that understand the unique demands of rare disease management.
Manufacturing & Distribution
At Aegerion Pharmaceuticals UK, we are committed to ensuring that patients around the world have timely and reliable access to high-quality, life-changing therapies. Our approach to manufacturing and distribution is designed to meet the specific needs of rare disease communities, where treatment access can be as critical as treatment efficacy.
Bolandit massa ltriceseros in cursus turpis massa tincid untdiam.
Global Manufacturing Standards
We partner with world-class contract manufacturing organizations (CMOs) that adhere to the highest international standards of Good Manufacturing Practice (GMP). These facilities are regularly audited and certified to meet stringent regulatory requirements in the UK, EU, US, and other global markets.
GMP-compliant facilities
Validated processes for sterile and oral formulations
Rigorous quality assurance and control systems
Batch traceability and pharmacovigilance integration
